Annual Current Assets
$8.69 M
-$2.64 M-23.32%
June 30, 2024
Summary
- As of February 7, 2025, INM annual total current assets is $8.69 million, with the most recent change of -$2.64 million (-23.32%) on June 30, 2024.
- During the last 3 years, INM annual current assets has risen by +$311.30 thousand (+3.72%).
- INM annual current assets is now -57.25% below its all-time high of $20.33 million, reached on June 30, 2018.
Performance
INM Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$7.28 M
-$1.41 M-16.22%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly total current assets is $7.28 million, with the most recent change of -$1.41 million (-16.22%) on September 30, 2024.
- Over the past year, INM quarterly current assets has dropped by -$2.78 million (-27.66%).
- INM quarterly current assets is now -64.19% below its all-time high of $20.33 million, reached on June 30, 2018.
Performance
INM Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
INM Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.3% | -27.7% |
3 y3 years | +3.7% | -24.1% |
5 y5 years | -38.5% | -29.0% |
INM Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -23.3% | +3.7% | -48.1% | at low |
5 y | 5-year | -38.5% | +37.7% | -54.4% | +42.3% |
alltime | all time | -57.3% | >+9999.0% | -64.2% | -100.0% |
InMed Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $7.28 M(-16.2%) |
Jun 2024 | $3.13 M(+12.9%) | $8.69 M(-13.7%) |
Mar 2024 | - | $10.06 M(-14.8%) |
Dec 2023 | - | $11.81 M(+42.4%) |
Sep 2023 | - | $8.30 M(-26.8%) |
Jun 2023 | $2.77 M(-13.0%) | $11.33 M(-4.3%) |
Mar 2023 | - | $11.84 M(-15.5%) |
Dec 2022 | - | $14.02 M(+21.4%) |
Sep 2022 | - | $11.54 M(+20.3%) |
Jun 2022 | $3.19 M(+127.4%) | $9.60 M(+9.7%) |
Mar 2022 | - | $8.75 M(-30.1%) |
Dec 2021 | - | $12.51 M(-21.7%) |
Sep 2021 | - | $15.98 M(+90.7%) |
Jun 2021 | $1.40 M(-5.9%) | $8.38 M(-23.1%) |
Mar 2021 | - | $10.90 M(+6.3%) |
Dec 2020 | - | $10.25 M(+100.3%) |
Sep 2020 | - | $5.12 M(-18.9%) |
Jun 2020 | $1.49 M(+57.7%) | $6.31 M(-12.7%) |
Mar 2020 | - | $7.23 M(-23.7%) |
Dec 2019 | - | $9.47 M(-16.7%) |
Sep 2019 | - | $11.37 M(-19.5%) |
Jun 2019 | $945.00 K(-6.5%) | $14.13 M(-10.6%) |
Mar 2019 | - | $15.80 M(-7.9%) |
Dec 2018 | - | $17.15 M(-11.4%) |
Sep 2018 | - | $19.36 M(-4.8%) |
Jun 2018 | $1.01 M(-5.5%) | $20.33 M(+87.9%) |
Mar 2018 | - | $10.82 M(+2.3%) |
Dec 2017 | - | $10.58 M(+111.9%) |
Sep 2017 | - | $4.99 M(-6.5%) |
Jun 2017 | $1.07 M(-5.4%) | $5.34 M(+134.0%) |
Mar 2017 | - | $2.28 M(+273.5%) |
Dec 2016 | - | $610.90 K(+168.3%) |
Sep 2016 | - | $227.70 K(+56.9%) |
Jun 2016 | $1.13 M(-0.4%) | $145.10 K(+69.3%) |
Mar 2016 | - | $85.70 K(-22.3%) |
Dec 2015 | - | $110.30 K(+37.0%) |
Sep 2015 | - | $80.50 K(-60.1%) |
Jun 2015 | $1.14 M(-19.1%) | $202.00 K(+129.3%) |
Mar 2015 | - | $88.10 K(-7.0%) |
Dec 2014 | - | $94.70 K(-49.5%) |
Sep 2014 | - | $187.50 K(+1.0%) |
Jun 2014 | $1.40 M(>+9900.0%) | $185.70 K(+2895.2%) |
Mar 2014 | - | $6200.00(+72.2%) |
Dec 2013 | - | $3600.00(+63.6%) |
Sep 2013 | - | $2200.00(-56.9%) |
Jun 2013 | $0.00 | $5100.00(-56.0%) |
Mar 2013 | - | $11.60 K(+12.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | - | $10.30 K(-58.1%) |
Sep 2012 | - | $24.60 K(-48.0%) |
Jun 2012 | $0.00(0.0%) | $47.30 K(-60.3%) |
Mar 2012 | - | $119.00 K(-7.6%) |
Dec 2011 | - | $128.80 K(-34.0%) |
Sep 2011 | - | $195.20 K(-21.4%) |
Jun 2011 | $0.00(-100.0%) | $248.50 K(-58.0%) |
Mar 2011 | - | $591.20 K(>+9900.0%) |
Dec 2010 | - | $0.00(-100.0%) |
Sep 2010 | - | $13.30 K(+2.3%) |
Jun 2010 | $124.50 K(+4193.1%) | $13.00 K(+5.7%) |
Mar 2010 | - | $12.30 K(+3.4%) |
Dec 2009 | - | $11.90 K(+1.7%) |
Sep 2009 | - | $11.70 K(-48.0%) |
Jun 2009 | $2900.00(-99.6%) | $22.50 K(-70.9%) |
Mar 2009 | - | $77.30 K(-29.7%) |
Dec 2008 | - | $109.90 K(-70.8%) |
Sep 2008 | - | $376.20 K(-36.1%) |
Jun 2008 | $792.80 K(+1805.8%) | $588.30 K(+48.4%) |
Mar 2008 | - | $396.40 K(-3.4%) |
Dec 2007 | - | $410.50 K(+26.0%) |
Sep 2007 | - | $325.70 K(-10.0%) |
Jun 2007 | $41.60 K(-78.5%) | $361.70 K(-42.6%) |
Mar 2007 | - | $630.50 K(+85.4%) |
Dec 2006 | - | $340.10 K(-3.0%) |
Sep 2006 | - | $350.60 K(-23.5%) |
Jun 2006 | $193.10 K(-46.2%) | $458.60 K(-19.0%) |
Mar 2006 | - | $566.30 K(-13.6%) |
Dec 2005 | - | $655.50 K(+18.1%) |
Sep 2005 | - | $555.00 K(-11.4%) |
Jun 2005 | $358.60 K(+21.8%) | $626.20 K(-49.4%) |
Mar 2005 | - | $1.24 M(-11.7%) |
Dec 2004 | - | $1.40 M(+425.4%) |
Sep 2004 | - | $266.90 K(+6.2%) |
Jul 2004 | $294.50 K(-60.7%) | $251.40 K(-28.5%) |
Apr 2004 | - | $351.80 K(+1.3%) |
Jan 2004 | - | $347.40 K(-35.2%) |
Oct 2003 | - | $536.40 K(+29.4%) |
Jul 2003 | $749.40 K(+118.0%) | $414.50 K(-31.4%) |
Apr 2003 | - | $604.10 K(-15.2%) |
Jan 2003 | - | $712.20 K(-16.8%) |
Oct 2002 | - | $855.60 K(-16.1%) |
Jul 2002 | $343.70 K(-85.1%) | $1.02 M(-14.9%) |
Apr 2002 | - | $1.20 M(-19.6%) |
Jan 2002 | - | $1.49 M(-15.0%) |
Oct 2001 | - | $1.75 M |
Jul 2001 | $2.30 M | - |
FAQ
- What is InMed Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual current assets year-on-year change?
- What is InMed Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly current assets year-on-year change?
What is InMed Pharmaceuticals annual total current assets?
The current annual current assets of INM is $8.69 M
What is the all time high annual current assets for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual total current assets is $20.33 M
What is InMed Pharmaceuticals annual current assets year-on-year change?
Over the past year, INM annual total current assets has changed by -$2.64 M (-23.32%)
What is InMed Pharmaceuticals quarterly total current assets?
The current quarterly current assets of INM is $7.28 M
What is the all time high quarterly current assets for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly total current assets is $20.33 M
What is InMed Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, INM quarterly total current assets has changed by -$2.78 M (-27.66%)